Defect-rich sonosensitizers based on CeO<sub>2</sub> with Schottky heterojunctions for boosting sonodynamic/chemodynamic synergistic therapy-Reference-Cited by-同舟云学术

Defect-rich sonosensitizers based on CeO₂ with Schottky heterojunctions for boosting sonodynamic/chemodynamic synergistic therapy

Published:2024 Issue:17 Volume:12 Page:4162-4171
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Zheng Haiyang¹²,Yin Na¹²,Lv Kehong¹²,Niu Rui¹²,Zhou Shijie¹²,Wang Yinghui¹²^ORCID,Zhang Hongjie¹²³^ORCID

Affiliation:

1. State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China

2. School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, P. R. China

3. Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China

Abstract

A defect-rich hollow Schottky heterojunction sonosensitizer, constructed by defect engineering and noble metal enrichment, exhibits an amplified treatment effect for sonodynamic therapy due to the inhibition effect of electron–hole pair recombination.

Funder

Youth Innovation Promotion Association of the Chinese Academy of Sciences

National Natural Science Foundation of China

National Key Research and Development Program of China

Jilin Provincial Scientific and Technological Development Program

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D4TB00084F

Reference57 articles.

1. NIR-activated upconversion nanoparticles/hydrogen-bonded organic framework nanocomposites for NIR-II imaging-guided cancer therapy

2. Tumor microenvironment-responsive modular integrated nanocomposites for magnetically targeted and photothermal enhanced catalytic therapy

3. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy

4. Nanomaterials in tumor immunotherapy: new strategies and challenges

5. Biomaterial-assisted photoimmunotherapy for synergistic suppression of cancer progression